Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Bolt Biotherapeutics
640 Galveston Drive
Redwood City, CA 94063
Phone: 650-665-9295
http://boltbio.com/

Bolt Biotherapeutics is a private biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of cancer therapeutics. These systemically-administered, tumor-targeted Boltbody™ therapeutics unleash the immune system to induce anti-tumor immunity. The company is led by a team with extensive oncology drug discovery and development experience. Bolt was founded by Dr. Ed Engleman, professor of pathology and medicine, Stanford Medicine, and its platform is based on technology exclusively licensed from Stanford University.

Key Contact
Name
Edgar G. Engleman, MD
Title
Founder & Director
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
02/05/19 $54,000,000 Series B Nan Fung
Novo Holdings
Vivo Capital
undisclosed
07/02/20 $93,500,000 Series C Novo Holdings
Pfizer Venture Investments
Pivotal bioVenture Partners
RA Capital
Rock Springs Capital
Samsara BioCapital
Sofinnova Ventures
Surveyor Capital
Vivo Capital
undisclosed